-+ 0.00%
-+ 0.00%
-+ 0.00%

Valerio Therapeutics Nears Final Deal for Etherna Immunotherapies Purchase

MT Newswires·08/17/2026 02:48:40
Listen to the news
02:48 AM EDT, 08/17/2026 (MT Newswires) -- Valerio Therapeutics (ALVIO.PA) said Monday that parties in the negotiations for its planned acquisition of technology platform company Etherna Immunotherapies are looking to finalize the deal for the transaction by Friday. The Paris-listed biotechnology company agreed to continue discussions for the deal amid an initial agreement for six weeks of exclusivity. Valerio is offering to acquire Etherna at an enterprise value of 30 million euros. The transaction has already received foreign direct investment clearance ahead of the final definitive transaction documentation.